|
US2011092549A1
|
|
Treatment of sepsis with 5-ethyl-1-phenyl-2(1H)-pyridone
|
|
CA2388840A1
|
|
Treatment of lymphomas, leukemias, breast carcinomas, astrocytomas, melanomas, leiomyomas, and related tumors
|
|
US6956044B1
|
|
Compositions and methods for treatment of epilepsy
|
|
AU2000237125B2
|
|
Compositions and methods for treatment of epilepsy
|
|
AU2627800A
|
|
Treatment of lymphomas, leukemias, and leiomyomas
|
|
CA2322994A1
|
|
Topical antiseptic compositions and methods
|
|
AU2751997A
|
|
Reparation and prevention of fibrotic lesions
|
|
AU7239996A
|
|
Inhibition of tumor necrosis factor alpha
|
|
ZA9607801B
|
|
Treatment of cytokine growth factor caused disorders
|
|
WO9627374A1
|
|
Treatment of cytokine growth factor caused disorders
|
|
EP0702551A1
|
|
Compositions and methods for reparation and prevention of fibrotic lesions
|
|
US5310562A
|
|
Composition and method for reparation and prevention of fibrotic lesions
|
|
WO9009176A1
|
|
Composition for reparation and prevention of fibrotic lesions
|
